Hypersensitivity to the active substance or to any of the excipients listed in Description.
Combined use of bleomycin and BRENTUXIMAB VEDOTIN (ADCETRIS) causes pulmonary toxicity (see Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education